Jeff L. Vacirca, Director at Odonate Therapeutics, Inc. (ODT), bought 1,000 shares at $23.30 ($23K) on 2017-12-12, disclosed to the SEC on 2017-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SPPI | BUY | 2022-12-02 | $23K | — | Filing → |
| ODT | BUY | 2019-06-28 | $500K | — | Filing → |
| ODT | BUY | 2019-03-07 | $51K | — | Filing → |